Case Study

End-To-End, GMP Production Platform For Synthon's Biologics Pipeline

Source: Sartorius
End-To-End, GMP Production Platform For Synthon’s Biologics Pipeline

“The engineering principles represented in the Sartorius bioreactor portfolio were essential in the smooth scale-up of cell culture from lab scale to a disposable 2000L reactor. Face-to-face meetings were instrumental in the design and quick implementation of all process equipment.” – Synthon

VIEW THE CASE STUDY!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Sartorius